Last reviewed · How we verify
NCT03993717
Solid Organ Transplant SHINGRIX
trial testing SHINGRIX in Kidney Transplant; Complications in 2 participants. Terminated before completion.
8 August 2020
Quick facts
| Lead sponsor | Emory University |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 2 |
| Start date | 30 January 2020 |
| Primary completion | 8 August 2020 |
| Estimated completion | 8 August 2020 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- SHINGRIX (shingrix) — full drug profile →
Conditions studied
- Kidney Transplant; Complications — all drugs for Kidney Transplant; Complications →
Sponsor
Emory University
Who can join
50 and older, any sex, with Kidney Transplant; Complications. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will assess the immune responses to the recombinant, AS01-adjuvanted varicella zoster virus subunit (HZ/su) vaccine or SHINGRIX in immunosuppressed patients, particularly those who have received a renal transplant, and aim to better understand if the vaccine and perhaps other adjuvanted vaccines are safe in these patients. 30 participants will be divided into 2 groups, one group will receive the 1st out of 2 doses of the vaccine 3-6 months after transplant per standard of care and the second group will receive the 1st out of 2 doses of the vaccine 12-36 months after the transplant per standard of care.The duration of the study is 180 days.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT03993717
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of SHINGRIX
Trials testing the same drug.
- NCT07285265 — Phase I Clinical Trial of Lyophilized Herpes Zoster mRNA Vaccine in Adults Aged 40 Years or Above · Phase 1 · active not recruiting
- NCT06335849 — A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years · Phase 1 · active not recruiting
- NCT03591770 — Shingrix Vaccine in Patients With Moderate to Severe Ulcerative Colitis on Tofacitinib · Phase 4 · terminated
Other recruiting trials for Kidney Transplant; Complications
Currently open trials in the same condition.
- NCT07531966 — Vascular Complications After Kidney Transplantation · recruiting
- NCT06958796 — Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV) · Phase 4 · recruiting
- NCT06798909 — Kidney Transplant Preemptive Therapy or Prophylaxis for CMV Prevention in D+R Recipients · Phase 3 · recruiting
- NCT07033858 — Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation · NA · recruiting
- NCT05782543 — Renal Ex Vivo Warm Advanced Resuscitation Through Machine Perfusion · NA · recruiting
Other Emory University trials
Trials by the same sponsor.
- NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study · NA · withdrawn
- NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait · NA · not yet recruiting
- NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose · NA · not yet recruiting
- NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I · Phase 2 · recruiting
- NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03993717 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Emory University
- Last refreshed: 20 February 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03993717.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing